Literature DB >> 30354547

Predicting Length of Stay and the Need for Postacute Care After Acute Myocardial Infarction to Improve Healthcare Efficiency.

Jason H Wasfy1, Kevin F Kennedy2, Frederick A Masoudi3, Timothy G Ferris4, Suzanne V Arnold2, Vinay Kini3, Pamela Peterson3, Jeptha P Curtis5, Amit P Amin6, Steven M Bradley7, William J French8, John Messenger3, P Michael Ho3, John A Spertus2.   

Abstract

Background To improve value in the care of patients with acute myocardial infarction (MI), payment models increasingly hold providers accountable for costs. As such, providers need tools to predict length of stay (LOS) during hospitalization and the likelihood of needing postacute care facilities after discharge for acute MI patients. We developed models to estimate risk for prolonged LOS and postacute care for acute MI patients at time of hospital admission to facilitate coordinated care planning. Methods and Results We identified patients in the National Cardiovascular Data Registry ACTION registry (Acute Coronary Treatment and Intervention Outcomes Network) who were discharged alive after hospitalization for acute MI between July 1, 2008 and March 31, 2017. Within a 70% random sample (Training cohort) we developed hierarchical, proportional odds models to predict LOS and hierarchical logistic regression models to predict discharge to postacute care. Models were validated in the remaining 30%. Of 633 737 patients in the Training cohort, 16.8% had a prolonged LOS (≥7 days) and 7.8% were discharged to a postacute facility (extended care, a transitional care unit, or rehabilitation). Model discrimination was moderate in the validation dataset for predicting LOS (C statistic=0.640) and strong for predicting discharge to postacute care (C statistic=0.827). For both models, discrimination was similar in ST-segment-elevation MI and non-ST-segment-elevation MI subgroups and calibration was excellent. Conclusions These models developed in a national registry can be used at the time of initial hospitalization to predict LOS and discharge to postacute facilities. Prospective testing of these models is needed to establish how they can improve care coordination and lower costs.

Entities:  

Keywords:  acute myocardial infarction; delivery of health care; hospitalization; length of stay; rehabilitation; transitional care

Mesh:

Year:  2018        PMID: 30354547      PMCID: PMC6207219          DOI: 10.1161/CIRCOUTCOMES.118.004635

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  25 in total

1.  Evaluating Discrimination of Risk Prediction Models: The C Statistic.

Authors:  Michael J Pencina; Ralph B D'Agostino
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

2.  Frailty is an independent prognostic marker in elderly patients with myocardial infarction.

Authors:  Gonzalo Luis Alonso Salinas; Marcelo Sanmartin; Marina Pascual Izco; Luis Miguel Rincon; Pablo Pastor Pueyo; Alvaro Marco Del Castillo; Alberto Garcia Guerrero; Pedro Caravaca Perez; Alejandro Recio-Mayoral; Asuncion Camino; Manuel Jimenez-Mena; José Luis Zamorano
Journal:  Clin Cardiol       Date:  2017-07-16       Impact factor: 2.882

3.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

4.  MACRA and Cardiology-The Devil Is in the Details.

Authors:  Lauren G Gilstrap; Karen E Joynt
Journal:  JAMA Cardiol       Date:  2017-11-01       Impact factor: 14.676

5.  Readmissions, Observation, and the Hospital Readmissions Reduction Program.

Authors:  Rachael B Zuckerman; Steven H Sheingold; E John Orav; Joel Ruhter; Arnold M Epstein
Journal:  N Engl J Med       Date:  2016-02-24       Impact factor: 91.245

6.  Association of Coded Severity With Readmission Reduction After the Hospital Readmissions Reduction Program.

Authors:  Andrew M Ibrahim; Justin B Dimick; Shashank S Sinha; John M Hollingsworth; Ushapoorna Nuliyalu; Andrew M Ryan
Journal:  JAMA Intern Med       Date:  2018-02-01       Impact factor: 21.873

7.  Modeling continuous response variables using ordinal regression.

Authors:  Qi Liu; Bryan E Shepherd; Chun Li; Frank E Harrell
Journal:  Stat Med       Date:  2017-09-05       Impact factor: 2.373

8.  Population trends in the incidence and outcomes of acute myocardial infarction.

Authors:  Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

9.  Current Risk Adjustment and Comorbidity Index Underperformance in Predicting Post-Acute Utilization and Hospital Readmissions After Joint Replacements: Implications for Comprehensive Care for Joint Replacement Model.

Authors:  Amit Kumar; Amol Karmarkar; Brian Downer; Amit Vashist; Deepak Adhikari; Soham Al Snih; Kenneth Ottenbacher
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-10-09       Impact factor: 4.794

10.  Development and application of a population-oriented measure of ambulatory care case-mix.

Authors:  J P Weiner; B H Starfield; D M Steinwachs; L M Mumford
Journal:  Med Care       Date:  1991-05       Impact factor: 2.983

View more
  3 in total

1.  Systematic review of prediction models for postacute care destination decision-making.

Authors:  Erin E Kennedy; Kathryn H Bowles; Subhash Aryal
Journal:  J Am Med Inform Assoc       Date:  2021-12-28       Impact factor: 4.497

2.  Home-Time After Discharge Among Patients With Type 2 Myocardial Infarction.

Authors:  Cian P McCarthy; Sean Murphy; Saad Rehman; Maeve Jones-O'Connor; David S Olshan; Joshua A Cohen; Jinghan Cui; Avinainder Singh; Muthiah Vaduganathan; James L Januzzi; Jason H Wasfy
Journal:  J Am Heart Assoc       Date:  2020-05-08       Impact factor: 5.501

3.  Predictors allowing early discharge after interventional treatment of acute coronary syndrome patients.

Authors:  Dávid Bauer; Marek Neuberg; Markéta Nováčková; Petr Mašek; Viktor Kočka; Zuzana Moťovská; Petr Toušek
Journal:  Eur Heart J Suppl       Date:  2022-03-30       Impact factor: 1.624

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.